Corneal Cross-Linking (CXL)
Keratoconus Corneal Cross-Linking (CXL) with Epioxa is a minimally invasive treatment designed to strengthen the cornea and slow or stop the progression of keratoconus.
During the procedure, Epioxa (riboflavin ophthalmic solution) is applied to the surface of the cornea. Unlike traditional cross-linking, the epithelium (the cornea’s protective outer layer) is left in place.
Key benefit
CXL primarily prevents further worsening of keratoconus; it is not primarily intended to eliminate the need for glasses or contact lenses.